ArticleClinicoEconomics and outcomes research : CEOR2017

Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain.

Santiago Grau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.